Correction: Identifying patients at risk for severe exacerbations of asthma: Development and external validation of a multivariable prediction model (Thorax (2016) 71 (838-846) DOI: 10.1136/thoraxjnl-2015-208138);Identifying patients at risk for severe exacerbations of asthma: Development and external validation of a multivariable prediction model

Thorax

Volumn 71, Issue 9, 2016, Pages 838-846

  Loymans, Rik J B ^a   Honkoop, Persijn J ^b   Termeer, Evelien H ^c   Snoeck Stroband, Jiska B ^b   Assendelft, Willem J J ^b,c   Schermer, Tjard R J ^c   Chung, Kian Fan ^d   Sousa, Ana R ^e   Sterk, Peter J ^a   Reddel, Helen K ^f   Sont, Jacob K ^b   Ter Riet, Gerben ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asthma Epidemiology; Asthma in primary care

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; CHRONIC SINUSITIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FRACTION OF EXHALED NITRIC OXIDE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE ASSESSMENT; RESPIRATORY TRACT PARAMETERS; SMOKING; SPIROMETRY; ADVERSE EFFECTS; FORCED EXPIRATORY VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ANTIASTHMATIC AGENT;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SPIROMETRY; YOUNG ADULT;

EID: 84963960243     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-208138corr1     Document Type: Erratum

References (28)

1. GINA (Global Initiative for Asthma) Global strategy for asthma management and prevention. 2015. http://www.ginasthma.org
2. Jackson DJ, Sykes A, Mallia P, et al. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011;128: 1165-74.
3. Ivanova JI, Bergman R, Birnbaum HG, et al. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol 2012;129:1229-35.
4. Loymans RJ, Gemperli A, Cohen J, et al. Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ 2014;:348:g3009.
5. Thomson NC, Chaudhuri R. Identification and management of adults with asthma prone to exacerbations: can we do better? BMC Pulm Med 2008;8:27.
6. Miller MK, Lee JH, Miller DP, et al., TENOR Study Group. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007;101:481-9.
7. Kitch BT, Paltiel AD, Kuntz KM, et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest 2004;126:1875-82.
8. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14: 902-7.
9. Greenberg S. Asthma exacerbations: predisposing factors and prediction rules. Curr Opin Allergy Clin Immunol 2013;13:225-36.
10. Osborne ML, Pedula KL, O'Hollaren M, et al. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest 2007;132:1151-61.
11. Eisner MD, Yegin A, Trzaskoma B. Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma. Chest 2012;141:58-65.
12. Miller MK, Lee JH, Blanc PD, et al. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma Eur Respir J. 2006;28:1145-55.
13. Bateman ED, Buhl R, O'Byrne PM, et al. Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations. J Allergy Clin Immunol 2015;135:1457-64.
14. Honkoop PJ, Loijmans RJ, Termeer EH, et al. Asthma Control Cost-Utility Randomized Trial Evaluation (ACCURATE) Study Group. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care. J Allergy Clin Immunol 2015;135:682-8.
15. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99.
16. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99.
17. Royston P, Sauerbrei W. Multivariable Model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. West Sussex, UK: John Wiley and Sons, 2008.
18. Steyerberg EW, Borsboom GJ, van Houwelingen HC, et al. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med 2004;23:2567-86.
19. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631-60.
20. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128-38.
21. Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J 2015;46:1308-21.
22. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007;165:710-18.
23. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:405-13.
24. Van Wonderen KE, Van Der Mark LB, Mohrs J, et al. Different definitions in childhood asthma: how dependable is the dependent variable? Eur Respir J 2010;36:48-56.
25. Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015;46:622-39.
26. Korevaar DA, Westerhof GA, Wang J, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med 2015;3:290-300.
27. Yawn BP, Wollan PC, Bertram SL, et al. Asthma treatment in a population-based cohort: putting step-up and step-down treatment changes in context. Mayo Clin Proc 2007;82:414-21.
28. Diette GB, Patino CM, Merriman B, et al. Patient factors that physicians use to assign asthma treatment. Arch Intern Med 2007;167:1360-6.